Childhood Asthma and Covid 19

IF 0.3 Q4 ALLERGY

Astim Allerji Immunoloji Pub Date : 2020-09-23 DOI:10.21911/AAI.561

Ö. Soyer

引用次数: 0

Abstract

Coronavirus disease 2019 (Covid 19) is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV 2) and causes lymphopenia, immunosuppression, inefficient T and B cell immunity, cytokine storm, and destructive tissue inflammation Since COVID 19 is a multi-system disease predominantly affecting the lungs, there is doubt on whether chronic lung diseases place patients at higher risk and SARS CoV2 leads to asthma exacerbation None of the studies have reported asthma or recurrent wheezing as a comorbidity or risk factor for Covid 19 in children up to now Notably, further studies are needed to explore the relationship between Covid 19 and asthma to improve clinical practice and decrease morbidity and mortality

查看原文本刊更多论文

儿童哮喘与新冠肺炎19

2019冠状病毒病（新冠肺炎19）由严重急性呼吸综合征冠状病毒-2（SARS CoV 2）引起，并导致淋巴细胞减少、免疫抑制、T和B细胞免疫效率低下、细胞因子风暴和破坏性组织炎症。由于Covid 19是一种主要影响肺部的多系统疾病，对于慢性肺部疾病是否使患者处于更高的风险中以及SARS-CoV2是否导致哮喘恶化存在疑问。迄今为止，没有研究报告哮喘或复发性喘息是儿童新冠肺炎19的合并症或危险因素。值得注意的是，需要进一步的研究来探索新冠肺炎19与哮喘之间的关系，以改善临床实践并降低发病率和死亡率

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Astim Allerji Immunoloji ALLERGY-

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： Asthma Allergy Immunology has been published three times a year in April, August and December as the official and periodical journal of the Turkish National Society of Allergy and Clinical Immunology since 2003. All articles published in the journal have been available online since 2003. A peer reviewed system is used in evaluation of the manuscripts submitted to Asthma Allergy Immunology. The official language of the journal is English. The aim of the journal is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal. The target reader population of the Asthma Allergy Immunology includes specialists and residents of allergy and clinical immunology, pulmonology, internal medicine, pediatrics, dermatology and otolaryngology as well as physicians working in other fields of medicine interested in allergy and immunological diseases.